These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
2. Exhaled breath condensate nitrite in premature infants with bronchopulmonary dysplasia. Yen E; Weinberger BI; Laumbach RJ; Ohman-Strickland PA; Vetrano AM; Gow AM; Ramagopal M J Neonatal Perinatal Med; 2018; 11(4):399-407. PubMed ID: 30040745 [TBL] [Abstract][Full Text] [Related]
3. Correlates of Elevated Interleukin-6 and 8-Hydroxy-2'-Deoxyguanosine Levels in Tracheal Aspirates from Very Low Birth Weight Infants Who Develop Bronchopulmonary Dysplasia. Hsiao CC; Chang JC; Tsao LY; Yang RC; Chen HN; Lee CH; Lin CY; Tsai YG Pediatr Neonatol; 2017 Feb; 58(1):63-69. PubMed ID: 27321203 [TBL] [Abstract][Full Text] [Related]
4. Elevation of interleukin-8 and interleukin-6 precedes the influx of neutrophils in tracheal aspirates from preterm infants who develop bronchopulmonary dysplasia. Munshi UK; Niu JO; Siddiq MM; Parton LA Pediatr Pulmonol; 1997 Nov; 24(5):331-6. PubMed ID: 9407566 [TBL] [Abstract][Full Text] [Related]
5. Inflammatory Mediators in Tracheal Aspirates of Preterm Infants Participating in a Randomized Trial of Inhaled Nitric Oxide. Laube M; Amann E; Uhlig U; Yang Y; Fuchs HW; Zemlin M; Mercier JC; Maier RF; Hummler HD; Uhlig S; Thome UH PLoS One; 2017; 12(1):e0169352. PubMed ID: 28046032 [TBL] [Abstract][Full Text] [Related]
6. Early increase in endothelin-1 in tracheal aspirates of preterm infants: correlation with bronchopulmonary dysplasia. Niu JO; Munshi UK; Siddiq MM; Parton LA J Pediatr; 1998 Jun; 132(6):965-70. PubMed ID: 9627587 [TBL] [Abstract][Full Text] [Related]
7. Ceramides in tracheal aspirates of preterm infants: Marker for bronchopulmonary dysplasia. van Mastrigt E; Zweekhorst S; Bol B; Tibboel J; van Rosmalen J; Samsom JN; Kroon AA; de Jongste JC; Reiss IKM; Post M; Pijnenburg MW PLoS One; 2018; 13(1):e0185969. PubMed ID: 29346372 [TBL] [Abstract][Full Text] [Related]
8. Preterm infants with high polyunsaturated fatty acid and plasmalogen content in tracheal aspirates develop bronchopulmonary dysplasia less often. Rüdiger M; von Baehr A; Haupt R; Wauer RR; Rüstow B Crit Care Med; 2000 May; 28(5):1572-7. PubMed ID: 10834714 [TBL] [Abstract][Full Text] [Related]
9. Low serum IGF-1 and increased cytokine levels in tracheal aspirate samples are associated with bronchopulmonary dysplasia. Yılmaz C; Köksal N; Özkan H; Dorum BA; Bağcı O Turk J Pediatr; 2017; 59(2):122-129. PubMed ID: 29276864 [TBL] [Abstract][Full Text] [Related]
10. The airway microbiome of intubated premature infants: characteristics and changes that predict the development of bronchopulmonary dysplasia. Lohmann P; Luna RA; Hollister EB; Devaraj S; Mistretta TA; Welty SE; Versalovic J Pediatr Res; 2014 Sep; 76(3):294-301. PubMed ID: 24941215 [TBL] [Abstract][Full Text] [Related]
11. Exosomal microRNA predicts and protects against severe bronchopulmonary dysplasia in extremely premature infants. Lal CV; Olave N; Travers C; Rezonzew G; Dolma K; Simpson A; Halloran B; Aghai Z; Das P; Sharma N; Xu X; Genschmer K; Russell D; Szul T; Yi N; Blalock JE; Gaggar A; Bhandari V; Ambalavanan N JCI Insight; 2018 Mar; 3(5):. PubMed ID: 29515035 [TBL] [Abstract][Full Text] [Related]
12. The Utility of Comprehensive Metabolic Panel Tests for the Prediction of Bronchopulmonary Dysplasia in Extremely Premature Infants. Chen X; Lin B; Xiong X; Sun P; Kong Y; Yang C Dis Markers; 2019; 2019():5681954. PubMed ID: 31772691 [TBL] [Abstract][Full Text] [Related]
13. Neonatal hematological parameters and the risk of moderate-severe bronchopulmonary dysplasia in extremely premature infants. Chen X; Li H; Qiu X; Yang C; Walther FJ BMC Pediatr; 2019 Apr; 19(1):138. PubMed ID: 31039810 [TBL] [Abstract][Full Text] [Related]
14. Increase of interleukin-6 in tracheal aspirate at birth: a predictor of subsequent bronchopulmonary dysplasia in preterm infants. Choi CW; Kim BI; Kim HS; Park JD; Choi JH; Son DW Acta Paediatr; 2006 Jan; 95(1):38-43. PubMed ID: 16373294 [TBL] [Abstract][Full Text] [Related]
15. Mesenchymal stromal cells and TGF-β1 in tracheal aspirate of premature infants: early predictors for bronchopulmonary dysplasia? Aly H; Mansi Y; Ez El Din Z; Gabr Metwally H; Sabry A J Perinat Med; 2019 May; 47(4):470-477. PubMed ID: 30789824 [TBL] [Abstract][Full Text] [Related]
16. Peptide growth factors in tracheal aspirates of mechanically ventilated preterm neonates. Ambalavanan N; Novak ZE Pediatr Res; 2003 Feb; 53(2):240-4. PubMed ID: 12538781 [TBL] [Abstract][Full Text] [Related]
17. Bronchopulmonary dysplasia is associated with reduced oral nitrate reductase activity in extremely preterm infants. Gentle SJ; Ahmed KA; Yi N; Morrow CD; Ambalavanan N; Lal CV; Patel RP Redox Biol; 2021 Jan; 38():101782. PubMed ID: 33166868 [TBL] [Abstract][Full Text] [Related]
18. Early airway microbial metagenomic and metabolomic signatures are associated with development of severe bronchopulmonary dysplasia. Lal CV; Kandasamy J; Dolma K; Ramani M; Kumar R; Wilson L; Aghai Z; Barnes S; Blalock JE; Gaggar A; Bhandari V; Ambalavanan N Am J Physiol Lung Cell Mol Physiol; 2018 Nov; 315(5):L810-L815. PubMed ID: 30113227 [TBL] [Abstract][Full Text] [Related]
19. Association between early metabolic acidosis and bronchopulmonary dysplasia/death in preterm infants born at less than 28 weeks' gestation: an observational cohort study. Notz L; Adams M; Bassler D; Boos V BMC Pediatr; 2024 Sep; 24(1):605. PubMed ID: 39342228 [TBL] [Abstract][Full Text] [Related]
20. Exploring clinical, echocardiographic and molecular biomarkers to predict bronchopulmonary dysplasia. Alvarez-Fuente M; Moreno L; Lopez-Ortego P; Arruza L; Avila-Alvarez A; Muro M; Gutierrez E; Zozaya C; Sanchez-Helguera G; Elorza D; Martinez-Ramas A; Villar G; Labrandero C; Martinez L; Casado T; Cuadrado I; Del Cerro MJ PLoS One; 2019; 14(3):e0213210. PubMed ID: 30840669 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]